Catégorie : Points saillants de la recherche

New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent

New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent

A carbohydrate-derived drug shows promise as a treatment to slow progression of the most common form of muscular dystrophy.

Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract

Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract

A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease

fr_CAFrench
Remonter en haut de la page